Hermans LE, Steegen K, ter Heine R, et al. Pi drug-level testing as a screening tool for drug resistance In 2nd-line ART failure. CROI 2019.Themed Discussion TD-03: Let's check in! New tools for monitoring ART and PrEP adherence. CROI 2019, oral presentation 461.
Langwerkend cabotegravir en rilpivirine elke 8 weken niet inferieur aan elke 4 weken
mrt 2021 | HIV, Virale infecties